| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |